Search the Newsreel

How ABBV Stock Moved Away From Its Peer Group

AbbVie (ABBV) has shown strong fundamental performance with high revenue growth and operating margins, yet its stock returns significantly lag behind peers like Merck and Johnson & Johnson. This disconnect is attributed to the market pricing in future competitive threats to AbbVie's key drug …

Las acciones de AbbVie enfrentan volatilidad con fortaleza en resultados, pero la resistencia sigue siendo clave: análisis semanal

Mountview Estates AGM Reveals Shareholder Dissent on Board Votes

Mountview Estates P.L.C. Approves Final Dividend Payment

AbbVie Inc. $ABBV Shares Bought by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC increased its stake in AbbVie Inc. (NYSE:ABBV) by 7.5% in the second quarter, bringing its total holdings to 134,579 shares valued at $33.9 million. This comes as AbbVie reported strong quarterly results, beating EPS and revenue estimates, …

BTIG downgrades Apogee Therapeutics stock rating after AbbVie deal

BTIG has downgraded Apogee Therapeutics Inc (NASDAQ:APGE) to Neutral from Buy after shareholders approved the company's acquisition by AbbVie Inc (NYSE:ABBV) for $10.9 billion, or $135.11 per share. This deal, which sees Apogee's stock trading near its 52-week high with a significant return, is …

Avient Corporation $AVNT Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in Avient Corporation (NYSE:AVNT) by 93.4% in Q1 2026, selling over 150,000 shares. Despite this, institutional investors collectively own 95.48% of Avient, which recently exceeded quarterly earnings and revenue expectations. Analysts maintain a "Moderate Buy" rating for …

Assenagon Asset Management S.A. Takes Position in Avient Corporation $AVNT

Assenagon Asset Management S.A. has acquired a new position in Avient Corporation (NYSE:AVNT), purchasing 254,716 shares valued at approximately $9.4 million. This acquisition makes Assenagon Asset Management S.A. the owner of about 0.28% of Avient, a company that has recently beaten earnings expectations and …

Cardinal Capital Management Inc. Buys 21,206 Shares of AbbVie Inc. $ABBV

Cardinal Capital Management Inc. increased its stake in AbbVie Inc. by 8.4% during the second quarter, purchasing an additional 21,206 shares to bring its total holdings to 273,719 shares valued at approximately $68.9 million. Institutional investors collectively own 70.23% of ABBV, and analysts maintain …

5 Revealing Analyst Questions From Navient’s Q2 Earnings Call

Grupo Supervielle (SUPV) returns to profit with stronger margins and capital in 2Q26

Grupo Supervielle returned to profitability in Q2 2026, reporting AR$12.8 billion in attributable net income, driven by stronger net financial income and expanded net interest margin. The bank also achieved significant cost savings through a 17% headcount reduction and improved asset quality with a …

Viewtrix Technology Sets Board Meeting to Approve Interim Results and Dividend Plan

BrightView (BV) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026, at 8:30 a.m. ET CALL PARTICIPANTS Vice President of Finance and Investor Relations - Chris StoczkoPresident and Chief Executive Officer - Dale AsplundChief Financial Officer - Brett Urban TAKEAWAYS Total Revenue -- $717.6 million, …

GODSEY & GIBB, INC's AbbVie Inc(ABBV) Holding History

GODSEY & GIBB, INC holds 74,257.00 shares of AbbVie Inc (ABBV) as of June 30, 2026, valued at $18.69 million, representing 1.53% of their stock portfolio. The firm's initial trade was in Q2 2021, and they have made 9 purchases and 9 sales of …

AbbVie (ABBV) Wins Canada Reimbursement Backing For Adult Migraine Treatment

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. AbbVie (NYSE: ABBV) received a recommendation from Canada's Drug Agency to reimburse UBRELVY for the acute treatment of migraine in adults. The decision …

AbbVie (ABBV) Gains On Botox Filing, Is The 9% Discount Still There?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. AbbVie (ABBV) is back in focus after Allergan Aesthetics reported that the FDA accepted a supplemental Biologics License Application for Botox Cosmetic targeting masseter muscle prominence in …

AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?

This article compares AbbVie and CVS Health as investment opportunities in 2026, highlighting their distinct business models and risk profiles. AbbVie, a biopharmaceutical giant, is favored for its focused operations and exciting growth trajectory, particularly with its immunology portfolio. CVS Health, an integrated healthcare …

Grupo Supervielle to report second-quarter earnings after US market close

Grupo Supervielle announced that it will release its second-quarter and first-half 2026 results on August 10, 2026, after the US market closes. The company will host a videoconference on August 11, 2026, at 11:00 a.m. ET to discuss these results. The news brief was …

Highview Merger Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Highview Merger Corp. (HVMC) earns $3.6M on $237.7M SPAC trust in Q2 2026

Highview Merger Corp. (HVMC), a Cayman Islands SPAC, reported a net income of $1.9 million for Q2 2026 and $3.6 million year-to-date, primarily from interest earned on its $237.7 million Trust Account. Despite its financial performance driven by interest income, the company faces "going …

Grupo Supervielle S.A. 2026 Q2 - Results - Earnings Call Presentation (NYSE:SUPV) 2026-08-11

Mountview Estates PLC Half-year Report (2851X)

How Much Did Immunology Drugs Contribute to AbbVie's Q2 Performance?

AbbVie ABBV announced encouraging second-quarter 2026 results last month, which beat expectations for both earnings and sales. A significant portion of this growth came from the continued strength of its two blockbuster immunology medications, Skyrizi and Rinvoq, which together accounted for more than 47% …

Avient (AVNT) is a Great Momentum Stock: Should You Buy?

Avient (AVNT) is identified as a strong momentum stock with a Zacks Momentum Style Score of 'A' and a Zacks Rank of #2 (Buy). The article highlights Avient's significant short-term price performance, outperforming its industry, and positive earnings estimate revisions as key drivers for …

Viemed (VMD) Q2 2026 Earnings Call Transcript

Viemed Healthcare reported record Q2 2026 revenue of $78.1 million, a 24% year-over-year increase, driven by record ventilator patient counts and growth in sleep therapy and maternal health. The company also announced an all-time high of 12,635 active ventilator patients and significant expansion in …

Grupo Supervielle (NYSE:SUPV) Shares Gap Up Following Strong Earnings

Grupo Supervielle (NYSE:SUPV) shares gapped up by 5% following the announcement of better-than-expected quarterly earnings, reporting $0.10 EPS and $233.55 million in revenue. Despite a consensus "Hold" rating from analysts, institutional interest in the company increased significantly. The stock's performance led to an opening …

BrightView Holdings, Inc. (7BV.F) Stock Price, News, Quote & History

This page provides an overview of BrightView Holdings, Inc. (7BV.F) stock, including its current price, news, and historical data. It details the company's performance, showing a 1.04% gain as of the reported time, and compares its trailing total returns against the S&P 500 benchmark …

How Navient Corporation (JSM) Affects Rotational Strategy Timing

The article analyzes Navient Corporation (NYSE: JSM) through AI models, identifying a neutral sentiment across all time horizons and an oscillation pattern. It presents three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis highlights an exceptional …

Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices

Updated program delivers simplified savings, greater benefits transparency, and expanded opportunities for practice growth Introduces new rewards opportunities for customer segments, including first-time APP members, growing practices, and long-standing loyal customers IRVINE, Calif., Aug. 11, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, today …

Grupo Supervielle Returns to Profit in 2Q26 as Cost Cuts and Margin Gains Strengthen Outlook

AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?

AbbVie (NYSE: ABBV) is aiming high with its $10.6 billion planned purchase of Apogee Therapeutics (NASDAQ: APGE). The deal, pending regulatory approvals, is expected to close in the third quarter. The move is designed to supplement the pharmaceutical giant's already strong immunology portfolio. However, …

AbbVie Inc. $ABBV Position Cut by Handelsbanken Fonder AB

Handelsbanken Fonder AB reduced its stake in AbbVie Inc. by 1.4% during the second quarter, selling 19,132 shares and now owning 1,362,464 shares worth $342.85 million. Despite this, AbbVie remains a "Moderate Buy" among analysts, with recent positive news including the acquisition of Apogee …

Vietnam Manufacturing & Export Processing Swings to Interim Loss as Revenue Falls

Carolina Wealth Advisors LLC Purchases 7,626 Shares of AbbVie Inc. $ABBV

Carolina Wealth Advisors LLC increased its stake in AbbVie Inc. by 68.6% in the second quarter, purchasing an additional 7,626 shares and bringing its total holdings to 18,741 shares valued at $4.716 million. Other institutional investors have also adjusted their positions in AbbVie, with …

First Trust Advisors LP Lowers Holdings in Navient Corporation $NAVI

Grupo Supervielle reports Q2 results

* Grupo Supervielle press release [https://seekingalpha.com/pr/20613852-grupo-supervielle-reports-2q26-results] (SUPV [https://seekingalpha.com/symbol/SUPV]): Q2 adjusted net income of Ps.36.2 billion in 2Q26 and Ps.43.4 billion in 1H26. * The efficiency ratio improved to 63.4% from 68.9% supported by stronger revenues, while excluding extraordinary severance charges it stood at 52.3%. …